{
    "Trade/Device Name(s)": [
        "EUROIMMUN EUROLINE Profile Autoimmune Liver Disease 8 Ag (IgG)",
        "EUROLINE Profile Autoimmune Liver Disease 8 Ag (IgG) Kit"
    ],
    "Submitter Information": "EUROIMMUN US INC.",
    "510(k) Number": "K113439",
    "Predicate Device Reference 510(k) Number(s)": [
        "K052262",
        "K050662",
        "K040885",
        "K000535",
        "K021482"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DBM",
        "NUM",
        "NRI",
        "NIY",
        "NBS"
    ],
    "Summary Letter Date": "April 10, 2013",
    "Summary Letter Received Date": "April 11, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.5090",
        "21CFR866.5660"
    ],
    "Regulation Name(s)": [
        "Antimitochondrial antibody immunological test system",
        "Multiple autoantibodies immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "AMA-M2",
        "M2-3E (BPO)",
        "Sp100",
        "PML",
        "gp210",
        "LKM-1",
        "LC-1",
        "SLA/LP"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Li-heparin tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunoblot",
        "Enzyme immunoassay (ELISA)",
        "Enzyme-linked immunosorbent assay"
    ],
    "Methodologies": [
        "Qualitative antibody detection",
        "Solid phase ELISA"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for EUROIMMUN EUROLINE Profile Autoimmune Liver Disease 8 Ag (IgG) kit for qualitative detection of IgG antibodies to eight liver-related autoantigens in serum and plasma",
    "Indications for Use Summary": "Intended for qualitative detection of IgG class antibodies against eight antigens (AMA-M2, M2-3E (BPO), Sp100, PML, gp210, LKM-1, LC-1, SLA/LP) in human serum and plasma as an aid in the diagnosis of autoimmune liver diseases, used in conjunction with other laboratory and clinical findings",
    "fda_folder": "Immunology"
}